Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential of cannabinoid derivative in pain and inflammation

Oct. 4, 1996

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

Endocrine drugs in development at Takeda

Sep. 27, 1996

U.S. clinical trials on nonsurgical alternative to hysterectomy ahead of schedule

Sep. 27, 1996

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

GI drugs under development at Takeda

Sep. 27, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...